Maternal Body Composition Regulates Placental Function
MBC
1 other identifier
observational
41
0 countries
N/A
Brief Summary
This study examined the relationships between maternal body composition, placental function, and fetal nutrition and body composition, and sought to determine the most accurate method of maternal body composition analysis in late pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2012
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 22, 2015
CompletedFirst Posted
Study publicly available on registry
October 26, 2015
CompletedJuly 8, 2025
October 1, 2015
1.2 years
October 22, 2015
July 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Compare maternal body fat measurement
Subjects presented for their study visits in the morning following an overnight fast. During the first visit, at 37-38 weeks' gestation, they underwent four measures: 1) ADP, 2) TBW volume by deuterium (2H2O) dilution, 3) skin-fold thickness (SFT), and 4) bioelectrical impedance analysis (BIA). To determine maternal FM (kg) without the presence of the fetus or placenta, and to avoid radiation exposure to the fetus, subjects returned for a second study visit two weeks postpartum for repeat measurements by the above methods plus a dual-energy x-ray absorptiometry scan (DXA) scan. Statistical analysis was performed using the R package Method Comparison Regression, version 1.2.1. Estimates of mean FM (kg) were compared by analysis of variance.
37 weeks gestation
Study Arms (3)
Normal weight
Overweight
Obese
Interventions
Eligibility Criteria
Healthy pregnant women at term with singleton gestation who were normal weight, overweight, or obese.
You may qualify if:
- Healthy pregnant women at term with singleton gestation
You may not qualify if:
- Medical condition requiring daily medication Fetal congenital anomalies Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Marshall NE, Murphy EJ, King JC, Haas EK, Lim JY, Wiedrick J, Thornburg KL, Purnell JQ. Comparison of multiple methods to measure maternal fat mass in late gestation. Am J Clin Nutr. 2016 Apr;103(4):1055-63. doi: 10.3945/ajcn.115.113464. Epub 2016 Feb 17.
PMID: 26888714DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
October 22, 2015
First Posted
October 26, 2015
Study Start
July 1, 2012
Primary Completion
September 1, 2013
Study Completion
December 1, 2013
Last Updated
July 8, 2025
Record last verified: 2015-10